全文获取类型
收费全文 | 12909篇 |
免费 | 1322篇 |
国内免费 | 5篇 |
出版年
2023年 | 84篇 |
2022年 | 194篇 |
2021年 | 392篇 |
2020年 | 224篇 |
2019年 | 306篇 |
2018年 | 318篇 |
2017年 | 252篇 |
2016年 | 436篇 |
2015年 | 787篇 |
2014年 | 788篇 |
2013年 | 861篇 |
2012年 | 1148篇 |
2011年 | 1046篇 |
2010年 | 586篇 |
2009年 | 463篇 |
2008年 | 652篇 |
2007年 | 666篇 |
2006年 | 560篇 |
2005年 | 494篇 |
2004年 | 482篇 |
2003年 | 410篇 |
2002年 | 383篇 |
2001年 | 118篇 |
2000年 | 102篇 |
1999年 | 116篇 |
1998年 | 114篇 |
1997年 | 66篇 |
1996年 | 70篇 |
1995年 | 57篇 |
1994年 | 56篇 |
1993年 | 66篇 |
1992年 | 90篇 |
1991年 | 77篇 |
1990年 | 85篇 |
1989年 | 72篇 |
1988年 | 65篇 |
1987年 | 74篇 |
1986年 | 59篇 |
1985年 | 79篇 |
1984年 | 79篇 |
1983年 | 67篇 |
1982年 | 55篇 |
1981年 | 57篇 |
1980年 | 71篇 |
1979年 | 63篇 |
1978年 | 65篇 |
1977年 | 50篇 |
1976年 | 66篇 |
1975年 | 51篇 |
1974年 | 64篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
271.
Bonnie L. Barrilleaux Benjamin W. Fischer-Valuck Jennifer K. Gilliam Donald G. Phinney Kim C. O’Connor 《In vitro cellular & developmental biology. Animal》2010,46(6):566-572
Therapeutic administration of mesenchymal stem cells (MSCs) by systemic delivery utilizes the innate ability of the cells to home to damaged tissues, but it can be an inefficient process due to a limited knowledge of cellular cues that regulate migration and homing. Our lab recently discovered that a potent pro-inflammatory cytokine, macrophage migration inhibitory factor (MIF), inhibits MSC migration. Because MIF may act on multiple cellular targets, an activating antibody (CD74Ab) was employed in this study to examine the effect of one MIF receptor, CD74 (major histocompatibility complex class II-associated invariant chain), on MSC motility. CD74 activation inhibits in a dose-dependent manner up to 90% of in vitro migration of MSCs at 40 μg/ml CD74Ab (p?<?0.001), with consistent effects observed among three MSC donor preparations. A blocking peptide from the C-terminus of CD74 eliminates the effect of CD74Ab on MSCs. This suggests that MIF may act on MSCs, at least in part, through CD74. Late-passage MSCs exhibit less chemokinesis than those at passage 2. However, MSCs remain responsive to CD74 activation during ex vivo expansion: MSC migration is inhibited ~2-fold in the presence of 5 µg/ml CD74Ab at passage 9 vs. ~3-fold at passage 2 (p?<?0.001). Consistent with this result, there were no significant differences in CD74 expression at all tested passages or after CD74Ab exposure. Targeting CD74 to regulate migration and homing potentially may be a useful strategy to improve the efficacy of a variety of MSC therapies, including those that require ex vivo expansion. 相似文献
272.
273.
Christine Ackerman Adam E. Locke Eleanor Feingold Benjamin Reshey Karina Espana Janita Thusberg Sean Mooney Lora J.H. Bean Kenneth J. Dooley Clifford L. Cua Roger H. Reeves Stephanie L. Sherman Cheryl L. Maslen 《American journal of human genetics》2012,91(4):646-659
About half of people with trisomy 21 have a congenital heart defect (CHD), whereas the remainder have a structurally normal heart, demonstrating that trisomy 21 is a significant risk factor but is not causal for abnormal heart development. Atrioventricular septal defects (AVSD) are the most commonly occurring heart defects in Down syndrome (DS), and ∼65% of all AVSD is associated with DS. We used a candidate-gene approach among individuals with DS and complete AVSD (cases = 141) and DS with no CHD (controls = 141) to determine whether rare genetic variants in genes involved in atrioventricular valvuloseptal morphogenesis contribute to AVSD in this sensitized population. We found a significant excess (p < 0.0001) of variants predicted to be deleterious in cases compared to controls. At the most stringent level of filtering, we found potentially damaging variants in nearly 20% of cases but fewer than 3% of controls. The variants with the highest probability of being damaging in cases only were found in six genes: COL6A1, COL6A2, CRELD1, FBLN2, FRZB, and GATA5. Several of the case-specific variants were recurrent in unrelated individuals, occurring in 10% of cases studied. No variants with an equal probability of being damaging were found in controls, demonstrating a highly specific association with AVSD. Of note, all of these genes are in the VEGF-A pathway, even though the candidate genes analyzed in this study represented numerous biochemical and developmental pathways, suggesting that rare variants in the VEGF-A pathway might contribute to the genetic underpinnings of AVSD in humans. 相似文献
274.
275.
W. H. Elliott 《The Biochemical journal》1960,74(1):90-94
276.
277.
Gretchen A Casazza Kevin A Jacobs Sang-Hoon Suh Benjamin F Miller Michael A Horning George A Brooks 《Journal of applied physiology》2004,97(1):302-309
We examined the effects of menstrual cycle phase and oral contraceptive (OC) use on triglyceride mobilization during 90 min of rest and 60 min of leg ergometry exercise at 45 and 65% peak O(2) uptake (Vo(2 peak)) in eight moderately physically active, eumenorrheic women (24.8 +/- 1.2 yr). Subjects were tested during the follicular phase (FP) and the luteal phase (LP) before OC use and during the inactive phase (IP) and high-dose phase (HP) after 4 complete mo of OC use. Glycerol rate of appearance (R(a)), a measure of triglyceride mobilization, was determined in a 3-h postabsorptive state using a primed constant infusion of [1,1,2,3,3-(2)H]glycerol. Before OC use (BOC), there were no significant differences between FP and LP in any of the variables studied. Dietary composition, exercise patterns, plasma glycerol concentrations, growth hormone concentrations, and exercise respiratory exchange ratio did not change with OC use. However, 4 mo of OC use significantly (P < 0.05) increased glycerol R(a) in HP during exercise at 45% Vo(2 peak) (6.2 +/- 0.2, 6.5 +/- 0.4, and 7.7 +/- 1.1 micromol.kg(-1).min(-1) for BOC, IP, and HP, respectively) and in IP and HP at 65% Vo(2 peak) (6.6 +/- 0.1, 8.2 +/- 0.6, and 8.1 +/- 0.7 micromol.kg(-1).min(-1) for BOC, IP, and HP, respectively). Plasma cortisol concentrations were significantly higher with OC use at rest and during exercise at 45 and 65% Vo(2 peak). In summary, although fluctuations of endogenous ovarian steroids have little effect on triglyceride mobilization, the synthetic ovarian steroids found in OCs increase triglyceride mobilization and plasma cortisol concentrations in exercising women. We conclude that the hierarchy of effects of ovarian steroids and their analogs on triglyceride mobilization in exercising women is as follows: energy flux > OC use > recent carbohydrate nutrition, menstrual cycle effects. 相似文献
278.
279.
280.
Properties of urease fractions separated on cm-cellulose 总被引:1,自引:0,他引:1